Teva Pharmaceutical Industries Limited Buys Stake in MediWound for $163 Million; Teva Will Also Pay $167 Million to Market Polyheal Products

TEL AVIV, Nov 9 (Reuters) - Israel-based Teva Pharmaceutical Industries (TEVA.TA) will pay $163 million to raise its stake in Mediwound to 51 percent to gain access to wound-healing products.

Back to news